Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
Patients that received brachytherapy showed 42% reduction in risk of cancer specific mortality.
»
09/23/22
PKC-ζ mediated reduction of the extracellular vesicles-associated TGF-β1 overcomes radiotherapy resistance in breast cancer
Radiotherapy resulted inincreased expression of t intratumoral TGF-β1.
»
04/07/23
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial
CAB high-risk had worst DRFi.
»
04/14/23
Claudin-4-adhesion signaling drives breast cancer metabolism and progression via liver X receptor beta;
CLDN4 signaling targets AKT phosphorylation site S432 in LXR beta;.
»
04/14/23
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate Cancer.
Higher rates of PCSM and metastatic disease observed in men who were screened only once.
»
10/05/22
B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma.
Clonogenic ability of A375 cells decreased by downregulating Sox2.
»
04/13/23
High-risk human papillomavirus 16/18 associated with improved survival in sinonasal squamous cell carcinoma.
Hispanic patients had 2.36 times higher prevalence of non-HPV16/18 sinonasal cancer.
»
12/21/22
Antitumor efficacy of dual blockade with encorafenib plus cetuximab in combination with chemotherapy in human BRAFV600E mutant colorectal cancer.
FOLFOX in combination with E+C as first-line, followed by E+C +/- 5-FU as maintenance therapy, most effective strategy.
»
04/07/23
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
Progression-free survival of TILsub high patients significantly longer than that of TILsub Low.
»
11/24/22
Giant supratentorial brain tumors in children: functional outcome and progression-free survival analysis.
Patients with postoperative FFS> 16 have worse PFS than patients with postoperative FSS <15.
»
11/29/22
< Prev
Next >